Search Results - "Issmail L"

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection.

Authors: Weiß R Issmail L Rockstroh A et al.

Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Nov 15; Vol. 13, pp. 1279147. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE

Low-Energy Electron Irradiation of Tick-Borne Encephalitis Virus Provides a Protective Inactivated Vaccine.

Authors: Finkensieper J Issmail L Fertey J et al.

Source: Frontiers in immunology [Front Immunol] 2022 Mar 07; Vol. 13, pp. 825702. Date of Electronic Publication: 2022 Mar 07 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity.

Authors: Herrmann A Gege C Wangen C et al.

Source: Antiviral research [Antiviral Res] 2024 Nov; Vol. 231, pp. 106008. Date of Electronic Publication: 2024 Sep 19.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines.

Authors: Khudainazarova, Nelli S. Granovskiy, Dmitriy L. Kondakova, Olga A. et al.

Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11979. 54p.

Pharmaceutical Strategies for West Nile Virus in Europe, an Underrecognized Cause of Severe Disease and Mortality in Older Adults: From Supportive Care to Antiviral Development.

Authors: Soraci, Luca Biscetti, Leonardo Corsonello, Andrea et al.

Source: Pharmaceuticals (14248247). Feb2026, Vol. 19 Issue 2, p302. 30p.

Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations.

Authors: Pinzon Burgos, Eduar Fernando Camacho Ortega, Sigrid Atkinson, Ben et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p1081. 34p.

Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system.

Authors: Reus P Guthmann H Uhlig N et al.

Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2023 Dec; Vol. 364, pp. 654-671. Date of Electronic Publication: 2023 Nov 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

Comprehensive Identification and Mechanistic Evaluation of Novel DHODH Inhibitors as Potent Broad-Spectrum Antiviral Agents.

Authors: Zhang, Chao Sun, Shiyang Xie, Huiru et al.

Source: Pharmaceuticals (14248247). Sep2025, Vol. 18 Issue 9, p1416. 24p.

Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry.

Authors: Urbanowicz, Krzysztof Opielka, Mikolaj Stegmann, Kim M. et al.

Source: Nucleosides, Nucleotides & Nucleic Acids. 2024, Vol. 43 Issue 8, p813-821. 9p.

Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?

Authors: Klessing, Stephan Peter, Antonia Sophia Fraedrich, Kirsten et al.

Source: Viruses (1999-4915). Feb2023, Vol. 15 Issue 2, p397. 10p.

Membrane-Targeting Antivirals.

Authors: Krasilnikov, Maxim S. Denisov, Vladislav S. Korshun, Vladimir A. et al.

Source: International Journal of Molecular Sciences. Aug2025, Vol. 26 Issue 15, p7276. 31p.

Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.

Authors: Issmail L Ramsbeck D Jäger C et al.

Source: Antiviral research [Antiviral Res] 2023 Mar; Vol. 211, pp. 105547. Date of Electronic Publication: 2023 Jan 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model.

Authors: Eberlein, Valentina Ahrends, Mareike Bayer, Lea et al.

Source: Viruses (1999-4915). Sep2023, Vol. 15 Issue 9, p1846. 17p.

Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses.

Authors: Weil T Kirupakaran A Le MH et al.

Source: JACS Au [JACS Au] 2022 Sep 06; Vol. 2 (9), pp. 2187-2202. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101775714 Publication Model: eCollection Cited Medium: Internet ISSN: 2691-3704 (Electronic) Linking ISSN: 26913704 NLM ISO Abbreviation: JACS Au Subsets: PubMed not MEDLINE

Oral Delivery of mRNA Vaccine by Plant-Derived Extracellular Vesicle Carriers.

Authors: Pomatto, Margherita A. C. Gai, Chiara Negro, Federica et al.

Source: Cells (2073-4409). Jul2023, Vol. 12 Issue 14, p1826. 15p.

Impact of pH-Responsive Cisplatin/Ribavirin-Loaded Monodispersed Magnetic Silica Nanocomposite on A549 Lung Cancer Cells.

Authors: Almohazey, Dana Ravinayagam, Vijaya Dafalla, Hatim et al.

Source: Pharmaceutics. May2025, Vol. 17 Issue 5, p631. 16p.

Advancements and Challenges in Addressing Zoonotic Viral Infections with Epidemic and Pandemic Threats.

Authors: Fatima, Munazza An, Timothy Park, Pil-Gu et al.

Source: Viruses (1999-4915). Mar2025, Vol. 17 Issue 3, p352. 31p.

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication.

Authors: Stegmann KM Dickmanns A Heinen N et al.

Source: IScience [iScience] 2022 May 20; Vol. 25 (5), pp. 104293. Date of Electronic Publication: 2022 Apr 25.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses.

Authors: Kwiatkowska, Angelika Granicka, Ludomira H.

Source: Membranes. May2023, Vol. 13 Issue 5, p464. 24p.

Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson's Model.

Authors: Katamesh, Ahmed A. Abdel-Bar, Hend Mohamed Break, Mohammed Khaled Bin et al.

Source: Pharmaceutics. Feb2025, Vol. 17 Issue 2, p243. 27p.